Skip to content
The Food and Drug Administration (FDA) recommended COVID vaccine manufacturers modify the next round of COVID-19 booster shots to target the extremely contagious Omicron […]
FDA: Omicron variants should be included in fall boosters Read More »
The Supreme Court limited the Environmental Protection Agency’s (EPA) ability to regulate carbon emissions from power plants on Thursday, ruling 6-3 that “Congress had
Supreme Court limits EPA’s ability to reduce power plant emissions Read More »
On Thursday, the White House announced that “61 of the largest U.S. hospital and health sector companies have responded to the administration’s Health Sector
61 companies join White House Health Sector Climate Pledge Read More »
The House Appropriations Committee is set to mark up today the fiscal year 2023 spending bill for Health and Human Services (HHS), which would
Healthcare spending bill draft includes many BIO requests Read More »
As monkeypox virus cases increase in the United States, the Biden administration will begin distributing the monkeypox vaccine around the country, focusing on persons
U.S. to distribute 1.6 million doses of monkeypox vaccine by year’s end Read More »
The Vaccine and Related Biological Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) voted 19-2 in favor of including Omicron variants
FDA advisers call for Omicron-specific boosters Read More »
Shell will develop a new racing fuel for the NTT INDYCAR SERIES beginning in 2023, the oil company announced recently. The fuel is made
Shell will supply IndyCar with 100% renewable race fuel Read More »
Global agtech companies collected $3.3 billion across 222 deals in the first three months of 2022, marking a 15.5% quarter-over-quarter increase in deal value,
Investors sow record funds into agtech, says report Read More »
The Bayh-Dole Act was meant to encourage innovative research. However, some lawmakers are trying to change the intent of the law using the “march-in
‘Backdoor’ drug price controls will limit access to medicines, says expert Read More »
The FDA’s Accelerated Approval pathway has assisted America’s biotech industry in making remarkable advances over the last 30 years—but it has come under political
Accelerated Approval is under political attack, experts say Read More »
